Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Bexsero

GSK signs up to apply AI to drug discovery

Will work with Exscientia on 10 small molecule targets

- PMLiVE

GSK signs up to apply AI to drug discovery

Will work with Exscientia on 10 small molecule targets

- PMLiVE

GSK starts trial of Nucala to seek alternate indications

Asthma therapy drug to be used to target severe nasal polyposis

- PMLiVE

GSK makes case for revaccination with Shingrix

The pharma giant seeks regulatory approval to treat people aged 50 plus

dengue fever mosquito

GSK cues up regulatory filings for relapsing malaria drug

60% of patients on tafenoquine combination remained relapse-free for six months

- PMLiVE

GSK’s Nucala posts mixed results in COPD

Conflicting late-stage trials throw doubt on its prospects

- PMLiVE

GSK asthma app wins healthcare technology award

Health Tech & You prizes also go to HealthUnlocked and others

- PMLiVE

Walmsley suggests GSK needs bigger product launches

Says the firm should have fewer and more focused priorities

- PMLiVE

GSK and Regeneron tap into UK Biobank resource

Data collection project for genetic sequencing could deliver vital data within the next year

- PMLiVE

GSK hopes real-world data flu app will go viral

Flumji has been developed by MIT Connection Science

- PMLiVE

GSK’s Deborah Waterhouse to take over from ViiV’ Dominique Limet

She will become CEO designate at the HIV-focused firm in January

- PMLiVE

GSK files shingles vaccine Shingrix in Europe

Blockbuster hopeful would compete with Merck & Co’s Zostavax

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links